Lincoln Pharmaceuticals Limited, one of India’s leading healthcare companies, has launched a chewable Vitamin C + Zinc tablet called ‘Emmufast’ for the Indian market. The tablet is an evidence-based Vitamin C bio-active, in combination with zinc that boosts antiviral activity and protection against COVID-19, by developing natural immunity.
Ashish R Patel, Whole-Time Director-Lincoln Pharmaceuticals Limited said that during this COVID-19 pandemic, strong natural immunity & immunity boosters are the only way to protect against the Virus. Vitamin-C & Zinc tablets have become a necessity and important part of every human being in their daily life. With this launch, they aim to fill the gap in serving the healthcare requirement of the masses with their wide range of 600 and above formulations and help build-up the immunity of every Indian, naturally.
As it is a chewable tablet, geriatric and paediatric patients as well as travelling patients who may not have ready access to water have the most convenience in consumption as it is an easy swallowing dosage form with pleasant flavour. Company is committed to fighting the COVID-19 pandemic and working closely with the government and relevant stakeholders to ensure uninterrupted supply of medicines.
Market size for Vitamin C and Zinc tablets is estimated to be around INR 150 crore in India and growing at the rate of 15% per annum.